18128-Prostate Cancer-NA-458

Prostate Cancer

CYCLONE 2: A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Address

4708 Alliance Blvd, Suite 150
Plano, TX 75093
P: (972) 596-7801

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.